Bortezomib and daratumumab in refractory autoimmune hemolytic anemia
American Journal of Hematology · 2023-10 · 98 (10)
DOI: 10.1002/ajh.27025 ↗Kurz gefasst
Leserbrief in der Zeitschrift American Journal of Hematology, online erschienen am 07.07.2023. Verfasst von John McGlothlin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Anemia, Hemolytic, Autoimmune, Multiple Myeloma. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: John McGlothlin, Michelle Elliott, Animesh Pardanani, Meera Sridharan
Zitieren
APA
McGlothlin, J., Abeykoon, J., Al-Hattab, E., Ashrani, A. A., Elliott, M., Hook, C. C., Pardanani, A., Pruthi, R., Sridharan, M., Wolanskyj, A., Rouse, R., & Go, R. (2023). Bortezomib and daratumumab in refractory autoimmune hemolytic anemia. American Journal of Hematology, 98(10). https://doi.org/10.1002/ajh.27025
Vancouver
McGlothlin J, Abeykoon J, Al-Hattab E, Ashrani AA, Elliott M, Hook CC, et al. Bortezomib and daratumumab in refractory autoimmune hemolytic anemia. American Journal of Hematology. 2023;98(10). doi:10.1002/ajh.27025
BibTeX
@article{McGlothlin2023,
author = {McGlothlin, John and Abeykoon, Jithma and Al-Hattab, Eyad and Ashrani, Aneel A and Elliott, Michelle and Hook, C Christopher and Pardanani, Animesh and Pruthi, Rajiv and Sridharan, Meera and Wolanskyj, Alexandra and Rouse, Rachelle and Go, Ronald},
title = {Bortezomib and daratumumab in refractory autoimmune hemolytic anemia},
journal = {American Journal of Hematology},
year = {2023},
volume = {98},
number = {10},
doi = {10.1002/ajh.27025}
}
EUVIMED